Considering the absolute number of CD8+ CD20+ T cells, a statistically significant decrease of activated (CD25+) cells was observed in CLL compared to controls, particularly among CD8+ CD20+ Tc1 cells (Figures 6C, K). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.